Fluoroscopy and C-arm Market to Grow at US$ 4,290.5 Mn by 2024: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies
Fluoroscopy is an imaging procedure that uses X-Ray technology to take real-time images of the body, allowing doctors to see interior organs, muscles, and bones, and assisting them in making key surgical decisions with minimal patient discomfort. Originally, image intensifiers were employed in fluoroscopy equipment; however, new technology-based fluoroscopy systems use flat panel detectors for digital image processing, resulting in a significant reduction in the radiation dose is given to the patient.
During the
projection period (2016–2024), the global Fluoroscopy and C – Arms market is
expected to grow at a CAGR of 4.5 percent, with market revenue rising from US$
2,901.3 Mn in 2015 to US$ 4,290.5 Mn by 2024.
Over the
forecast period, rising awareness of interventional procedures is expected to
drive revenue growth in the worldwide Fluoroscopy & C – Arms market. A
change toward a value-based healthcare model, an increase in hospital mergers
and consolidations, a growing need for minimally invasive surgeries, and growing demand for advanced imaging equipment are all factors to consider.
The high
cost of fluoroscopy devices and C – Arms, on the other hand, is expected to
limit market expansion throughout the projection period. Due to the rising demand
for C – Arms in emerging economies, the worldwide Fluoroscopy & C – Arms market has attractive possibilities for major market players. In the coming
years, the industry is projected to see some major developments, the most
prominent of which is the increased use of mobile C – Arms over permanent
systems.
The global
Fluoroscopy and C – Arms market is divided into two segments: C – Arms and
Fluoroscopy Devices; and Hospitals, Diagnostic Centers, and Specialty Clinics.
The C – Arms segment of the worldwide Fluoroscopy and C – Arms market is
expected to account for 74.4 percent revenue share of the global Fluoroscopy
and C – Arms market by the end of 2016. In the category of end-users,
North
America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa
make up the five primary regions of the global Fluoroscopy and C – Arms market.
In the global Fluoroscopy and C – Arms industry, the North American market is
predicted to grow at the fastest rate throughout the forecast period. North America's
market is anticipated to account for 36.7 percent of the global market.
Fluoroscopy
and C – Arms demand is predicted to rise in North America due to increased
demand for new technology such as flat panel detectors and short cooldown
times. Over the projection period, the APAC market is expected to grow at a
CAGR of 4.2 percent, reaching US$ 677.5 Mn by 2024.
The leading
companies in the global Fluoroscopy and C – Arms market are GE Healthcare
(General Electric Company), Koninklijke Philips N.V., Siemens Healthineers
(Siemens AG), Hologic, Inc., and Ziehm Imaging. Due to the high prices of
fluoroscopy and C-Arms equipment, as well as the significant capital required
to manufacture the systems, the global market is extremely consolidated.

Comments
Post a Comment